Sign up to save your podcasts
Or
Share Advancing GI Diagnostics with Functional Gut Clinic and CDI: A Conversation with Dr. Anthony Hobson
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Advancing GI Diagnostics with Functional Gut Clinic and CDI: A Conversation with Dr. Anthony Hobson
In a recent conversation on Episode 5 of the Modern Gastro Podcast, Craig Strasnick, CEO of CDI, and Dr. Anthony Hobson, founder of the Functional Gut Clinic, explored their ongoing partnership and its impact. With nearly a decade of collaboration, their joint efforts have been instrumental in expanding access to advanced diagnostic tools for GI disorders, significantly influencing the field.
The Partnership's Evolution
The collaboration between CDI and Functional Gut Diagnostics began in 2016 with a shared mission to address the complexities of functional GI disorders. Dr. Hobson, a multifaceted professional—clinician, business owner, physiologist, and academic researcher—detailed how his diverse roles converge to enhance the technologies they offer. The partnership's goal is to integrate cutting-edge research with practical clinical applications to validate and improve diagnostic methods.
Craig highlighted the critical role of academic research in shaping clinical practice. By leveraging public domain research and literature, they aim to demonstrate the clinical utility of their diagnostics, ensuring that new technologies are both effective and evidence-based. This integration of research and practice has been pivotal in advancing their diagnostic solutions.
Hydrogen and Methane Breath Testing: A Cornerstone
One of the standout aspects of their approach is the use of hydrogen and methane breath testing for diagnosing Small Intestinal Bacterial Overgrowth (SIBO) and other functional gut disorders. Dr. Hobson explained that breath testing has become a cornerstone of their methodology, providing valuable insights into conditions like SIBO and motility issues.
Their research into breath testing has helped establish standard protocols and has influenced national guidelines in the UK. Despite some skepticism and resistance from parts of the medical community, the data supporting breath testing's efficacy continues to grow. Dr. Hobson shared how this testing not only assists in diagnosis but also plays a crucial role in assessing treatment efficacy and guiding dietary modifications.
The collaboration between CDI and the Functional Gut Clinic represents a significant advancement in the field of gastrointestinal diagnostics. By integrating academic research with clinical practice, maintaining a patient-centered focus, and addressing skepticism with evidence-based solutions, they are transforming the landscape of GI diagnostics.
Follow Dr. Hobson:
- https://www.linkedin.com/in/anthony-hobson-028309a/
- https://twitter.com/functionalgut
- https://www.facebook.com/FunctionalGutClinic
View all episodes
By Craig StrasnickIn a recent conversation on Episode 5 of the Modern Gastro Podcast, Craig Strasnick, CEO of CDI, and Dr. Anthony Hobson, founder of the Functional Gut Clinic, explored their ongoing partnership and its impact. With nearly a decade of collaboration, their joint efforts have been instrumental in expanding access to advanced diagnostic tools for GI disorders, significantly influencing the field.
The Partnership's Evolution
The collaboration between CDI and Functional Gut Diagnostics began in 2016 with a shared mission to address the complexities of functional GI disorders. Dr. Hobson, a multifaceted professional—clinician, business owner, physiologist, and academic researcher—detailed how his diverse roles converge to enhance the technologies they offer. The partnership's goal is to integrate cutting-edge research with practical clinical applications to validate and improve diagnostic methods.
Craig highlighted the critical role of academic research in shaping clinical practice. By leveraging public domain research and literature, they aim to demonstrate the clinical utility of their diagnostics, ensuring that new technologies are both effective and evidence-based. This integration of research and practice has been pivotal in advancing their diagnostic solutions.
Hydrogen and Methane Breath Testing: A Cornerstone
One of the standout aspects of their approach is the use of hydrogen and methane breath testing for diagnosing Small Intestinal Bacterial Overgrowth (SIBO) and other functional gut disorders. Dr. Hobson explained that breath testing has become a cornerstone of their methodology, providing valuable insights into conditions like SIBO and motility issues.
Their research into breath testing has helped establish standard protocols and has influenced national guidelines in the UK. Despite some skepticism and resistance from parts of the medical community, the data supporting breath testing's efficacy continues to grow. Dr. Hobson shared how this testing not only assists in diagnosis but also plays a crucial role in assessing treatment efficacy and guiding dietary modifications.
The collaboration between CDI and the Functional Gut Clinic represents a significant advancement in the field of gastrointestinal diagnostics. By integrating academic research with clinical practice, maintaining a patient-centered focus, and addressing skepticism with evidence-based solutions, they are transforming the landscape of GI diagnostics.
Follow Dr. Hobson:
- https://www.linkedin.com/in/anthony-hobson-028309a/
- https://twitter.com/functionalgut
- https://www.facebook.com/FunctionalGutClinic